79 related articles for article (PubMed ID: 8398181)
1. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells.
Zamora MA; Dempsey EC; Walchak SJ; Stelzner TJ
Am J Respir Cell Mol Biol; 1993 Oct; 9(4):429-33. PubMed ID: 8398181
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase.
Meoli DF; White RJ
Can J Physiol Pharmacol; 2010 Aug; 88(8):830-9. PubMed ID: 20725141
[TBL] [Abstract][Full Text] [Related]
3. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction.
LaDouceur DM; Flynn MA; Keiser JA; Reynolds E; Haleen SJ
Biochem Biophys Res Commun; 1993 Oct; 196(1):209-15. PubMed ID: 8216294
[TBL] [Abstract][Full Text] [Related]
4. The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis.
Ohlstein EH; Arleth A; Bryan H; Elliott JD; Sung CP
Eur J Pharmacol; 1992 Apr; 225(4):347-50. PubMed ID: 1323478
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors.
Hafizi S; Allen SP; Goodwin AT; Chester AH; Yacoub MH
Atherosclerosis; 1999 Oct; 146(2):351-9. PubMed ID: 10532691
[TBL] [Abstract][Full Text] [Related]
6. The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density.
Kanse SM; Wijelath E; Kanthou C; Newman P; Kakkar VV
Lab Invest; 1995 Mar; 72(3):376-82. PubMed ID: 7898056
[TBL] [Abstract][Full Text] [Related]
7. Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Yoshikawa J
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S84-9. PubMed ID: 9595408
[TBL] [Abstract][Full Text] [Related]
8. Binding and functional properties of endothelin receptor subtypes in the human prostate.
Kobayashi S; Tang R; Wang B; Opgenorth T; Langenstroer P; Shapiro E; Lepor H
Mol Pharmacol; 1994 Feb; 45(2):306-11. PubMed ID: 8114678
[TBL] [Abstract][Full Text] [Related]
9. BQ123, an ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation.
Bonvallet ST; Oka M; Yano M; Zamora MR; McMurtry IF; Stelzner TJ
J Cardiovasc Pharmacol; 1993 Jul; 22(1):39-43. PubMed ID: 7690094
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Hypertens; 2001 Apr; 19(4):731-9. PubMed ID: 11330876
[TBL] [Abstract][Full Text] [Related]
11. BQ-123 inhibits both endothelin 1 and endothelin 3 mediated C6 rat glioma cell proliferation suggesting an atypical endothelin receptor.
Sedo ; Provero P; Revoltella RP; Di Bartolo V; Beffy P; Mizrahi J
J Biol Regul Homeost Agents; 1993; 7(3):95-8. PubMed ID: 8135146
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia and endothelin-1 stimulate DNA synthesis of pulmonary artery smooth muscle cells.
Feng X; Cai Y
Chin Med Sci J; 1996 Mar; 11(1):28-31. PubMed ID: 9206115
[TBL] [Abstract][Full Text] [Related]
13. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells.
Rizvi MA; Katwa L; Spadone DP; Myers PR
J Mol Cell Cardiol; 1996 Feb; 28(2):243-52. PubMed ID: 8729057
[TBL] [Abstract][Full Text] [Related]
14. Nonselective ETA/ETB receptor antagonist blocks proliferation of rat vascular smooth muscle cells after balloon angioplasty.
Tsujino M; Hirata Y; Eguchi S; Watanabe T; Chatani F; Marumo F
Life Sci; 1995; 56(25):PL449-54. PubMed ID: 7791506
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor.
Iwasaki H; Eguchi S; Ueno H; Marumo F; Hirata Y
Endocrinology; 1999 Oct; 140(10):4659-68. PubMed ID: 10499523
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of diabetic bladder smooth muscle cell proliferation by endothelin receptor antagonists.
Mumtaz FH; Shukla N; Sullivan ME; Thompson CS; Khan MA; Morgan RJ; Stansby G; Mikhailidis DP
Urol Res; 2000 Aug; 28(4):254-9. PubMed ID: 11011965
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor subtypes in resistance arteries from humans and rats.
Deng LY; Li JS; Schiffrin EL
Cardiovasc Res; 1995 Apr; 29(4):532-5. PubMed ID: 7796447
[TBL] [Abstract][Full Text] [Related]
18. Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery.
Liu JJ; Casley D; Wojta J; Gallicchio M; Dauer R; Johnston CI; Buxton BF
Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):49-57. PubMed ID: 8156652
[TBL] [Abstract][Full Text] [Related]
19. Effects of human peptide endothelin-1 and two of its sterically unrestrained C-terminal fragments on coronaryvascular smooth muscle.
Drímal J; Drímal J; Orlický J; Janecek A; Kettmann V; Drímal D; Húzavová M
Gen Physiol Biophys; 2002 Mar; 21(1):3-14. PubMed ID: 12168722
[TBL] [Abstract][Full Text] [Related]
20. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells.
Weissberg PL; Witchell C; Davenport AP; Hesketh TR; Metcalfe JC
Atherosclerosis; 1990 Dec; 85(2-3):257-62. PubMed ID: 2102088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
